Helping Innovative Small Businesses in Pennsylvania Win Federal Funding.

The Innovation Partnership (IPart) is a statewide consortium of economic development, business assistance, and higher education organizations that provide early-stage technology companies with free proposal writing assistance, training, and financial assistance. The goal: Help Pennsylvania-based clients secure federal funding opportunities – Specifically, SBIR/STTR.

16 Years of Proven Results

0

Sbir Proposals Submitted

  • Sbir
  • Awards
  • Received
0

Sbir Award Value to Date

$0 Million

  • Phase I:$17.4M
  • Phase II:$19.4M
0
Travel & Training Awards
IPart Awards to Clients (MG/MV/FMA)
0

Totalling

$0

Submission

Win

Rate

0%

(Compared to National Avarage of between 14% - 17%)

The Power of Partnership

Success Stories

IPart is a tremendous asset to that entrepreneur who needs not only proposal funding but critical feedback for devising a winning SBIR proposal!

- Jorgen Penderson, RE 2 Robotics

The SBIR process is very challenging. IPart assistance can be invaluable to a vast majority of tech companies looking to submit well-prepared proposals for SBIR/STTR funding.

- Liz Brensinger, Green Heron Tools

It’s great that Pennsylvania has a program like the Innovation Partnership. It helps technology companies with the SBIR process and win these very important grant awards to move their companies forward.

- Bo Liang, Adesso Advanced Materials Inc.

The programs, assistance and advice the IPart provides helped us significantly in our proposal improvement and to ultimately win a Phase I STTR from the NSF.

- Kamrun Nahar, Impulse Technology

IPart’s peer review and funding for grant-writing assistance were extremely helpful in strengthening our federal submission and winning the award.

Jamin Steffen, Hepron Molecular Lab, Inc.

IPart’s pre-review technical feedback, demand for early proposal preparation, and Travel & Training funding greatly benefitted our company’s ability to secure the SBIR grant funding.

-Surbhi Jain, JBS Science Inc.

The IPart’s $3,000 MicroVoucher for grant-writing assistance is very helpful for the technology companies applying for these federal grants – while it seems like a small amount – we can use all of the help we can get.

Matt Handle, Skyran Biologics, Inc.

I think the IPART program is a vital component of the startup ecosystem in the Pittsburgh area. It provides an opportunity for non-academics and academics with limited grant writing experience to construct competitive federal grants to secure seed funding.

- Sanna Gaspard, Rubitection

Solicitations dates

See More
Agency/ProgramRelease DateOpen DateClose DateIPart Deadline
DOD SBIR 20.2 BAA
DOD STTR 20.B BAA
Pre-Release
5/6/20
6/3/20207/2/2020Thurs, 6/4/20
National Science Foundation (NSF)
(Project Pitch Required)
SBIR PhI 20527 STTR PhI 20528
COVID-19 Phase I Opportunities
NSF is offering fast turn-around time for COVID-19
related innovations
READ MORE HERE
12/18/193/6/203/6/20-6/4/20
6/5/20-9/3/20
9/4/20-12/3/20
(Submission Windows)

PPA 1st Draft
sent to IPart
6-5 weeks before
planned submission

PPA Submission
Dealine is
4 Weeks
before planned
federal submiss.
(rolling deadlines)>
USDA
USDA FY 2021
July 2020
July 202010/23/20Fri 9/25/20
EPA
EPA SBIR
June 2020
June 2020EO July 2020EO Jun Beg Jul 20
HHS (Health and Human Services)
NOT-OD-20-099

PHS 2020 Omnibus Solicitations of the NIH, CDC, & FDA
SBIR R43/44 & STTR, R41/42. Grant Applications
are scheduled to be published on May 22, 2020.
Modifications will include new and revised
research priorities/topics.
5/22/20
5/22/209/8/20
1/5/21
4/5/21
Tues 8/11/20
Tues 12/8/20
Mon 3/8/21
HHS Omnibus (NIH)
Clinical Trails not allowed:
PA-19-272 SBIR-NIH, CDC & FDA
PA-19-270 STTR-NIH
Clinical Trials Required:
PA-19-273 SBIR-NIH
PA-19-721 STTR-NIH
2019 Program Descriptions & Research Topics Document
2019 2019 SBA approved topics list for budget waivers
COVID-19 UPDATE - Check Notices of Special Interest
using search term "COVID" for competitive revision
opportunities
READ MORE
5/7/195/7/195/1/20Mon 4/6/20